Cormorant Asset Management, LP Axsome Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

$1.43 Billion
Q3 2024

A detailed history of Cormorant Asset Management, LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 400,000 shares of AXSM stock, worth $36.3 Million. This represents 2.52% of its overall portfolio holdings.

Number of Shares

400,000

Previous 400,000 -0.0%

Holding current value

$36.3 Million

Previous $32.2 Million 11.61%

% of portfolio

2.52%

Previous 2.48%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $26.3 Million - $32.2 Million	400,000 New	400,000 $32.2 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $2.34 Million - $3.61 Million	40,000 Added 13.33%	340,000 $24.4 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $1.46 Million - $1.88 Million	-25,000 Reduced 7.69%	300,000 $18.5 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $13 Million - $25.9 Million	325,000 New	325,000 $25.1 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $4.46 Million - $9.58 Million	205,000 New	205,000 $7.85 Million
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $10.1 Million - $14.7 Million	-200,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $3.32 Million - $4.33 Million	-50,000 Reduced 20.0%	200,000 $16.3 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $6.83 Million - $8.58 Million	-100,000 Reduced 28.57%	250,000 $17.8 Million
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $7.48 Million - $14.8 Million	-150,000 Reduced 30.0%	350,000 $28.8 Million
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $4.12 Million - $10.1 Million	-100,000 Reduced 16.67%	500,000 $29.4 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $10 Million - $63.7 Million	600,000 New	600,000 $62 Million

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account

Cormorant Asset Management, LP Axsome Therapeutics, Inc. Transaction History